Deterioration of visual quality and acuity as the first sign of ceroid lipofuscinosis type 3 (CLN3), a rare neurometabolic disease.
Journal Information
Full Title: Metab Brain Dis
Abbreviation: Metab Brain Dis
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Declarations Ethics approvalThis is an observational study and no ethical approval is required. Written informed consent was obtained from the parents for making diagnostic analyses in biological material from their children. Consent to participateWritten informed consent was obtained from the parents for making diagnostic analyses in biological material from their children and to use obtained results in scientific works (this is a retrospective study). Consent to publishNot applicable. Competing interestsThe authors have no relevant financial or non-financial interests to disclose. Competing interests The authors have no relevant financial or non-financial interests to disclose."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025